This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Union Hospital Tongji Medical College Hust. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xing Chen and Innovations in Tissue-Engineered Heart Valves.
Introduction
Xing Chen is an inventor based in Wuhan, China. His work includes research on a decellularized heart valve composite and its potential use in tissue-engineered heart valves. Chen is associated with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Latest Patents
Chen is named on 1 patent: “Decellularized heart valve (DHV) composite, and preparation method and use thereof.” The disclosed method modifies a decellularized heart valve with a copper chloride–dopamine hydrochloride solution, then treats it with a GDF11 solution to produce the composite. The patent describes using this material to prepare a tissue-engineered heart valve with remodeling and regeneration capabilities.
Career Highlights
The patent reflects an approach to heart-valve engineering that combines material modification with GDF11 treatment. Its stated aim is to support the development of valves capable of remodeling and regeneration.
Collaborations
Chen’s listed coworkers include Nianguo Dong and Ying Zhou. His institutional affiliation connects his work with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Conclusion
Xing Chen’s patent focuses on a decellularized heart valve composite and its potential application in regenerative tissue-engineered heart valves.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile